Medical visits for chemotherapy and chemotherapy-induced neutropenia: a survey of the impact on patient time and activities

BACKGROUND: Patients with cancer must make frequent visits to the clinic not only for chemotherapy but also for the management of treatment-related adverse effects. Neutropenia, the most common dose-limiting toxicity of myelosuppressive chemotherapy, has substantial clinical and economic consequence...

Descripción completa

Detalles Bibliográficos
Autores principales: Fortner, Barry V, Tauer, Kurt, Zhu, Ling, Okon, Theodore A, Moore, Kelley, Templeton, Davis, Schwartzberg, Lee
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC420468/
https://www.ncbi.nlm.nih.gov/pubmed/15153249
http://dx.doi.org/10.1186/1471-2407-4-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC420468/
https://www.ncbi.nlm.nih.gov/pubmed/15153249
http://dx.doi.org/10.1186/1471-2407-4-22

Ejemplares similares